• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新冠病毒肺炎加重终末期肾病所致心包积液并需行心包开窗引流术:一例报告

COVID-19 exacerbating ESRD induced pericardial effusion requiring pericardial window: A case report.

作者信息

Khan Aryaan, Hudson Michael L, Petree Tyler R

机构信息

University of Medicine and Health Sciences, Saint Kitts and Nevis.

Department of Surgery, Sinai Grace Hospital, Detroit Medical Center, Detroit, MI, USA.

出版信息

Int J Surg Case Rep. 2023 Aug;109:108565. doi: 10.1016/j.ijscr.2023.108565. Epub 2023 Jul 26.

DOI:10.1016/j.ijscr.2023.108565
PMID:37515850
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10407422/
Abstract

INTRODUCTION

Pericardial effusion can lead to cardiac tamponade requiring immediate management. Pericardial windows are an effective measure to surgically drain recurrent effusions.

PRESENTATION OF CASE

We present a case of a 53-year-old male with recurrent pericardial effusion secondary to ESRD and exacerbated by COVID-19 infection, describing the successful management of an uncommon clinical scenario. A sub-xiphoid pericardial window and right sided thoracostomy was performed.

DISCUSSION

There are limited case reports highlighting recurrent pericardial effusion management, secondary to ESRD and COVID-19 in a post renal transplant patient, through a subxiphoid pericardial window.

CONCLUSION

COVID-19 infection can exacerbate pericardial effusion in a patient with ESRD, post renal transplant. Preventing cardiac tamponade, a sub-xiphoid pericardial window remains an effective measure in treating recurrent pericardial effusion.

摘要

引言

心包积液可导致心脏压塞,需要立即进行处理。心包开窗术是手术引流复发性积液的有效措施。

病例介绍

我们报告一例53岁男性患者,因终末期肾病继发复发性心包积液,并因新冠病毒感染而加重,描述了对这一罕见临床情况的成功处理。进行了剑突下心包开窗术和右侧胸廓造口术。

讨论

关于肾移植术后因终末期肾病和新冠病毒感染继发复发性心包积液,通过剑突下心包开窗术进行处理的病例报告有限。

结论

新冠病毒感染可使肾移植术后终末期肾病患者的心包积液加重。为预防心脏压塞,剑突下心包开窗术仍是治疗复发性心包积液的有效措施。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ff5/10407422/83a586f71904/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ff5/10407422/90c907d1aba0/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ff5/10407422/5bd5d68374ff/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ff5/10407422/a83920bda3ec/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ff5/10407422/19dd9001ef95/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ff5/10407422/83a586f71904/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ff5/10407422/90c907d1aba0/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ff5/10407422/5bd5d68374ff/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ff5/10407422/a83920bda3ec/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ff5/10407422/19dd9001ef95/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ff5/10407422/83a586f71904/gr5.jpg

相似文献

1
COVID-19 exacerbating ESRD induced pericardial effusion requiring pericardial window: A case report.新冠病毒肺炎加重终末期肾病所致心包积液并需行心包开窗引流术:一例报告
Int J Surg Case Rep. 2023 Aug;109:108565. doi: 10.1016/j.ijscr.2023.108565. Epub 2023 Jul 26.
2
Pericardioperitoneal and pericardiopleural windows: A drainage technique for the treatment of recurrent cardiac tamponade. A case report.心包腹膜和心包胸膜开窗术:一种治疗复发性心脏压塞的引流技术。病例报告。
Int J Surg Case Rep. 2021 Jun;83:105962. doi: 10.1016/j.ijscr.2021.105962. Epub 2021 May 12.
3
Pericardial effusion and cardiac tamponade requiring pericardial window in an otherwise healthy 30-year-old patient with COVID-19: a case report.一名原本健康的30岁新冠肺炎患者出现心包积液和心脏压塞,需行心包开窗引流术:病例报告
J Med Case Rep. 2020 Sep 9;14(1):158. doi: 10.1186/s13256-020-02467-w.
4
Mid-Term Efficacy of Subxiphoid Versus Transpleural Pericardial Window for Pericardial Effusion.剑突下与经胸膜心包开窗术治疗心包积液的中期疗效
J Surg Res. 2020 Aug;252:9-15. doi: 10.1016/j.jss.2020.01.014. Epub 2020 Mar 23.
5
Fatal Cardiac Tamponade: The Lethal Progression of Acute-on-Chronic Pericardial Effusion.致命性心脏压塞:慢性心包积液急性进展的致死过程
Cureus. 2024 Jun 23;16(6):e62950. doi: 10.7759/cureus.62950. eCollection 2024 Jun.
6
A patient with recurrent breast cancer showing long-term survival after developing pericardial effusion and cardiac tamponade caused by carcinomatous pericarditis.一位患有复发性乳腺癌的患者,在罹患癌性心包炎导致的心包积液和心脏压塞后长期生存。
Breast Care (Basel). 2013 Mar;8(1):71-3. doi: 10.1159/000346831.
7
COVID-19 Presenting as Recurrent Pericardial Effusion.表现为复发性心包积液的新型冠状病毒肺炎
Cureus. 2021 Oct 11;13(10):e18652. doi: 10.7759/cureus.18652. eCollection 2021 Oct.
8
Contemporary outcomes after pericardial window surgery: impact of operative technique.心包开窗术后的当代疗效:手术技术的影响
J Cardiothorac Surg. 2016 Apr 26;11(1):73. doi: 10.1186/s13019-016-0466-3.
9
Recurrent pericardial effusion and tamponade after epicardial pacemaker lead placement: a case report.心外膜起搏器导线置入术后复发性心包积液和心脏压塞:一例报告
Eur Heart J Case Rep. 2022 Mar 11;6(4):ytac114. doi: 10.1093/ehjcr/ytac114. eCollection 2022 Apr.
10
Which treatment in pericardial effusion?心包积液应采用哪种治疗方法?
J Cardiovasc Surg (Torino). 2002 Oct;43(5):735-9.